BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week
May 16, 2024 16:55 ET
|
BIO-key International, Inc.
BIO-key Expects to File Audited 2023 Results on Form 10-K & Report Q1’24 Results with an Investor Call Next Week.
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari Medical
May 16, 2024 10:45 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inari Medical, Inc. (“Inari” or the “Company”)...
Blackboxstocks Files Form S-4 for Evtec Acquisition
May 16, 2024 08:00 ET
|
Blackboxstocks, Inc.
Blackboxstocks Files Form S-4 for Evtec Acquisition - Reports First Quarter Financial Results for Fintech Operations
J-Long Group Limited Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
May 16, 2024 07:25 ET
|
J-Long Group Limited
Ordinary shares will continue to trade on the Nasdaq Global Market, and the Company’s listing on such exchange is not affected by the receipt of the Notice HONG KONG, May 16, 2024 (GLOBE NEWSWIRE)...
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 18:00 ET
|
Vaccinex, Inc.
Last patient last visit in SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease in early June 2024. $8.2 million of new financing in Q1.
Oncocyte Reports First Quarter 2024 Financial Results
May 15, 2024 16:05 ET
|
OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sharecare
May 15, 2024 15:45 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sharecare, Inc. (“Sharecare” or the “Company”)...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics
May 15, 2024 15:30 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akero Therapeutics, Inc. (“Akero” or the...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sonder
May 15, 2024 15:30 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sonder Holdings Inc. (“Sonder” or the...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
May 15, 2024 15:15 ET
|
Faruqi & Faruqi LLP
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against QuidelOrtho Corporation (“QuidelOrtho” or the...